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1. Introduction 
1.1. Taxonomy and history 
Nocardiosis is an opportunistic, localized or disseminated granulomatous infection caused 
by an aerobic actinomycete most commonly found in soil, decomposing vegetation, and 
other organic matter, as well as in fresh and salt water 1. Infection most commonly occurs 
through the respiratory tract. Manifestations of disease range from cutaneous infection 
caused by traumatic inoculation of the organism in a normal host to severe hematogenous 
spread to pulmonary or central nervous system (CNS) disease in an immunocompromised 
host 2. 
Taxonomy of nocardia has undergone many revisions. Aerobic actinomycetes are bacteria 
belonging to the order Actinomycetales, Nocardia is a genus in the family Nocardiaceae. As 
Nocardiaceae branch into filaments they were misclassified as fungi. Like members of the 
genus Mycobacterium, the nocardiae contain tuberculostearic acids, but in contrast to 
mycobacteria, they also possess short-chain (40 to 60 carbon) mycolic acids and usually 
exhibit characteristic branching on Gram staining 3,4,5,6. More than 50 species have been 
identified by phenotypic and molecular methods. Originally referred to as Nocardia asteroides 
was later found to be a group of bacteria named N asteroides complex which was responsible 
for most of the human infections1. On the basis of drug susceptibility patterns N asteroides 
complex was later separated into different species: Nocardia abscessus, Nocardia brevicatena-
paucivorans complex, Nocardia nova complex, Nocardia transvalensis complex, Nocardia 
farcinica and Nocardia asteroids7. Nocardia cyriacigeorgica was recently differentiated from N 
asteroids 8. 
Some species are more prevalent in geographical locations with a specific climate. Nocardia 
brasiliensis, usually associated with cutaneous infection and mycetoma, is more commonly 
isolated in areas with tropical or subtropical climates and is often encountered in the 
southwestern or southeastern United States 9,10. Saubolle and Sussland recently reported that 
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nocardial infections in the United States seem to be more prevalent in the arid, warm 
climates of the southwest 11. 
The taxonomic history of the genus Nocardia is fraught with confusion and controversy. The 
organism initially placed in the genus Nocardia was isolated by veterinarian Edmond 
Nocard in 1888 from a case of bovine12. One year later, Trevisan characterized the organism 
and named it Nocardia farcinica. Taxonomic studies by Gordon and Mihm in 1962 found no 
phenotypic differences between Nocardia strain and strains of isolates known as “N. 
asteroides”13,14. Because of the uncertain taxonomic status of the N. farcinica type strain and 
because N. asteroides had become the most common designation of isolates of this genus, the 
name N. asteroides was chosen to replace N. farcinica as the type species of the genus 
Nocardia. 
Nocardia exhibits varying degrees of acid-fastness, depending on the mycolic acid 
composition in the cell wall and type of stain used 3. The modified Kinyoun acid-fast stain 
uses 1% sulfuric acid as a decolorizer (instead of the more potent hydrochloric acid used 
in the decoloration step in the Ziehl- Neelsen staining procedure), which enhances the 
ability of Nocardia to retain the colored fuchsin15. Unlike mycobacteria, Nocardia has a 
“beaded” acid-fast appearance on microscopy. Nocardia can resemble Actinomyces species 
on Gram stain; however, Actinomyces species are not acid-fast and grow under anaerobic 
conditions1. 
2. Epidemiology  
It has a universal distribution, affecting people mainly between 20-50 years of age 16. Males 
are more affected than females. Pathogenic species of Nocardia can be found in house dust, 
beach sand, garden soil, and swimming pools 15. Despite the occurrence of nocardiosis in 
many animals (e.g. cats, dogs, guinea pigs, and cattle), there is no evidence of respiratory 
spread from infected animals to humans17. There is also no evidence of person-to-person 
transmission. Patients with depressed cell-mediated immunity especially are at high risk for 
infection, including those with lymphoma, other malignancies, human immunodeficiency 
virus infection and solid-organ or hematopoietic stem cell transplant and those receiving 
long-term treatment with steroids or other immunosuppressive medications like 
azathioprine and cyclosporine18,19. Among stem cell transplant patients, nocardiosis can 
develop at varying time periods, which range from 2 to 3 months to 1 to 2 years after 
transplant. Among solid organ transplant recipients, Nocardia infection has a frequency of 
0.6% to 3% and has been well described in kidney, heart, and liver recipients20,21. A case 
control study of 5126 solid organ transplant recipients, Nocardia infection was found highest 
among lung transplant recipients, followed by recipients of heart, small bowel, kidney, and 
liver transplants22,23,24. Risk factors in these patients include the early rejection of grafts and 
intensive immunoupuppressive therapy. Use of azathioprine and prednisone or high-dose 
prednisone alone may pose a greater risk of development of nocardiosis than combination 
therapy with cyclosporine and prednisone together25,26. 
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With the comparatively recent advent of HIV infection, the incidence of nocardiosis has 
comparatively risen. It affects mainly rural more than the urban population and occurs in 
patients with CD4 T cell count less than 100 cells/µl. Such patients are more likely to 
develop pulmonary and extra pulmonary disease 2. Host resistance to nocardiosis 
depends on the number and phagocytic/lytic capability of the polymorphonuclear cells 
and the status of the cell mediated immunity. The last of this fails in AIDS patients and 
predisposes to severe forms of nocardiosis. However, low frequency of this complication 
in patients with advanced HIV can be attributed to sulphonamide therapy and the 
leading role of neutrophils in immune response to nocardia2. Intravenous drug abusers 
can be predisposed to cutaneous nocardiosis since direct inoculation through injections 
sites can occur, leading to abscesses2. Surgical wound infections due to N. farcinica has 
been described27. 
3. Microbiology 
The genus Nocardia are branched gram-positive (Figure 1), variably acid-fast, strictly aerobic 
bacteria, as they age, they fragment into rod-shaped or coccoid elements15. Nocardiosis 
bacteria induces abscess and granulomatous response in the skin. In hematoxilin & Eosin 
staining of nocardiosis shows abscess (collection of neutrophils) and granules (grains) 
(Figure 2). Grains are closely aggregated with a peripheral radial deposition of intensely 
eosinophilic material – a Hoeppli – Splendore (HS) reaction (Figure 3a and 3b). H&E stains 
demonstrate the bacilli poorly. They are 1 micrometer diameter , gram positive, Grocott 
silver positive, usually positive with Zeihl Neelson stain, this differentiate nocadiosis from 
actinomyces and related bacilli. The Grocott silver method is the most sensitive screening 
stain for nocardiosis. 
 
Figure 1. Gram positive filamentous bacteria showing branching, consistent with N.brazilienses 
 Histopathology – Reviews and Recent Advances 84 
 
Figure 2. Histopathology of nocardiosis showing grains with neutrophils around it 
 
Figure 3. a. Histopathology of nocardiosis with inflammatory cells around it (10x) 
b. 40x magnification showing irregularly staining granular structure surrounded by RBCs and necrotic 
tissue with few neutrophils disease 
On blood agar, filamentous colonies have a chalky white or cotton-ball appearance. Unlike 
Actinomadura, and Streptomyces species the catalase-positive nocardiae grows in a nutrient 
broth. They grow readily over most of the simple media e.g. Sabouraud's glucose agar, 
blood agar, brain-heart infusion agar, and Lowenstein-Jensen agar15. More vigorous growth 
is achieved by adding 10% carbon dioxide. On agar, colonies are usually rough with velvety 
surface because of the aerial hyphae (Figure 4). Most of the primary isolates are white or 
light orange and have a characteristic moldy or earthy odour. Optimum temperature for 
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growth is 370C but growth is slow and pure colonies are visible only after 48-72 hours of 
incubation. Before discarding, the culture should be observed for 2 weeks28. 
 
Figure 4. Powdery yellow colonies of N.braziliences on LJ medium 
Microscopic examination of gram-stained clinical specimens are thin, delicate, weakly to 
strongly gram-positive, irregularly stained or beaded branching filaments. A modified 
Ziehl-Neelsen stain, which decolorizes with 1% sulphuric acid instead of acid alcohol is the 
best technique for demonstrating nocardia17. There are multiple species, existing mainly in 
the soil, but human disease is mostly caused by Nocardia asteroides (so called because of 
star shaped colonies it produces in cultures). Nocardia are not visualized on hematoxylin and 
eosin stain of tissue or periodic acid-Schiff (PAS) stain for fungi. Methenamine silver 
preparations may reveal the organism in some instances. Routine blood cultures are not 
usually positive, but nocardia can be isolated from blood if biphasic blood culture systems 
are inoculated and incubated aerobically for up to 30 days15,17. Blood specimens are 
processed by centrifugation. Exudate, joint, CSF specimen and homogenized tissue 
specimens should be inoculated directly into media such as thioglycollate broth, trypticase 
soy broth or chopped-meat glucose broth. Serological methods including hemagglutination, 
precipitin, and complement-fixing antibody testing have a limited value because of a high 
degree of shared antigens and serological cross-reactivity among the heterogeneous 
pathogenic Nocardia species and other actinomycetes, especially Rhodococcus, Streptomyces, 
and Corynebacterium species 29. 
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Other Biochemical and molecular methods: DNA probing, PCR, PCR-RFLP. PCR analysis of 
16S rDNA is a useful tool to identify the species of nocardia. The application of this method 
has enabled the identification of nocardia in pathological specimens. It usually takes about 2 
weeks for microbiological isolation and antibiotic susceptibility tests in cases of nocardiosis, 
but real-time PCR analysis of 16S rDNA can be completed in a few hours. This is relatively 
rapid, because amplification is carried out in capillary glass tubes, which are used only in 
the lightcycler instrument.  
In RFLP analysis, the DNA sample is broken into pieces (digested) by restriction enzymes 
and the resulting restriction fragments are separated according to their lengths by gel 
electrophoresis. RFLP methodologies are a means for the rapid and accurate identification of 
clinical isolates of Nocardia species and far surpass the conventional biochemical methods in 
their discriminatory capabilities. 
4. Pathogenesis 
After entry of the organism response begins in the reticuloendothelial system with early 
mobilization of neutrophils, thus limiting the spread of infection 30. Later cell mediated 
immunity comes into a role and is triggered by activated macrophages, T cell population 
which causes direct lymphocyte-mediated toxicity to the organism. The interactions of 
phagocytic cells with nocardia depends on the virulence of the strain and with the growth 
phase of the nocardial cells. Virulent nocardia is attributed to complex cell wall glycolipids 
which inhibits phagosome - lysosome fusion and decreases lysosomal enzyme activity in 
macrophages, neutralizes phagosomal acidification, and even resists the oxidative killing 
mechanisms of phagocytes. In chronic granulomatous disease, neutrophils and 
macrophages fail to generate a burst of oxidative metabolism during phagocytosis, thus 
impairing the intracellular killing of catalase- positive bacteria such as Nocardia species 30. 
The host must ultimately mount a lymphocyte response and subsequently release antibody 
and/or lymphocyte signals enabling the phagocytic cells to kill N asteroides. Immune T cells 
effectively clear Nocardia species organisms from the lung and prevent extrapulmonary 
dissemination. Neutrophils predominate in the early lesions of nocardiosis, and infection 
progresses unless antimicrobial agents are given or CMI takes over. 
5. Clinical features 
5.1. Lung  
Pulmonary nocardiosis is the most common clinical presentation of infection because 
inhalation is the primary route of bacterial exposure17. Occasionally the gastrointestinal tract 
is penetrated, especially the appendix31. Rarely, pulmonary infection follows a dental or 
periodontal infection due to ingestion of contaminated food or raw vegetable material. 
Infection occurs in persons of all ages, even neonates. Men are affected three times as 
commonly as women 17. Patients on immunosuppressive drugs, chronic granulomatous 
disease 32,33,34, chronic alcoholism, diabetes mellitus, and human immunodeficiency virus 
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infection are also more susceptible to pulmonary infections with Nocardia. The onset of 
symptoms may be acute, subacute or chronic and untreated pulmonary nocardiosis can 
have several features similar to tuberculosis, including fever, weight loss, nonproductive 
cough, anorexia, night sweats, dyspnea, hemoptysis. Acute forms are particularly seen in 
the compromised host. 
Patients can exhibit pneumonia, abscess formation, bronchopneumonia, total consolidation 
(lobar or even multilobar), pleural involvement or even empyema which has been seen in 
up to 25% of cases. 
Pleural thickening or effusion can be seen radiologically. Pleural effusions can develop in up 
to one-third of patients. It can be very difficult clinically and radiographically to 
differentiate Nocardia from filamentous fungi (eg, aspergillosis, mucormycosis) or 
mycobacterial disease 17. Chronic long standing lung lesions can lead to sinus formation. 
Chest X ray can also show cavitation, consolidation, abscess formation or even miliary 
lesions. Rarely, Nocardia species organisms invade preexisting lung cavities, producing a 
"fungus ball" appearance. 
Tissues usually exhibit a mixed cellular response with polymorphonuclear leukocytes, 
macrophages, and lymphocytes. However, on occasion, tissue sections reveal a 
granulomatous reaction with central necrosis.  
Other uncommon features include tracheitis, bronchitis, pleuropulmonary fistula, 
mediastinitis with superior vena cava syndrome and sinusitis. 
6. Cutaneous involvement  
Primary cutaneous and soft tissue nocardiosis can result from traumatic injury to the skin 
that involves contamination with soil35. It can be clinically evident or self limiting. Many 
cases go underdiagnosed as gram stains and culture are not routinely done for most 
superficial skin infections. After skin inoculation, a superficial abscess, localized 
cellulitis,pustules, pyoderma, ulcerations or paronychia can develop healing with variable 
scarring (Figure 5a and 5b ). 
Cutaneous nocardiosis can resemble indolent soft tissue infections as caused by 
Staphylococcus aureus or streptococci. The infection can spread to the regional lymph nodes 
and produce a single or linear chain of nodular lesions resembling sporotrichosis. This 
lymphocutaneous nocardiosis is often called sporotrichoid nocardiosis. In more advanced 
cases, a mycetoma with a sinus tract development can occur. Mycetoma is a chronic, 
granulomatous, subcutaneous tissue infection caused by both bacteria (actinomycetoma) 
and fungi (eumycetoma). This chronic infection was termed Madura foot and eventually 
mycetoma, owing to its etiology. The hallmark triad of the disease includes tumefaction, 
fistulization of the abscess and extrusion of colored grains. The color of these extruded 
grains in the active phase of the disease offers a clue to diagnosis. The "dot-in-circle" sign 
has recently been proposed as a highly specific magnetic resonance imaging (MRI) and 
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ultrasonography (USG) sign of mycetoma, which may allow a noninvasive as well as early 
diagnosis. At least half of the mycetomas are caused by aerobic actinomycetes, mostly 
Nocardia species, whereas members of the genus Actinomadura are frequently recorded only 
in certain geographic locations 15. N brasiliensis is the most frequently recognized cause 
Nocardia induced mycetomas, but N asteroides, N otitidiscaviarum, and N transvalensis can also 
be etiologic organisms. 
 
Figure 5. a. Primary cutaneous nocardiosis with ulcerated lesions and scarring 
b. Photograph of the same patient with all lesions healing with scarring 
Cutaneous nocardiosis is characterized by one of two manifestations: primary cutaneous 
infection or disseminated infection with skin involvement. The two forms have different 
microbiological, clinical and prognostic features which is illustrated in table number 136.  
Nocardia bacteremia is not occasionally present but if occurs it can lead to infection in the 
eyes (keratitis), heart valves, liver, spleen, adrenal glands, thyroid gland, and other organ 
tissues. In a review of Nocardia bacteremia done in USA, 64% patients had concurrent 
pulmonary nocardiosis, 28% had concurrent cutaneous disease, and 19% had concurrent 
CNS disease and poor outcomes are correlated with acute onset of nocardiosis (duration less 
than 1 month ), late identification of nocardia, involvement of more than 2 sites and lack of 
proper treatment.  
Post traumatic keratitis and endophthalmitis with compound-fracture infection or 
poststemotomy mediastinitis and postoperative nosocomial N farcinica wound infections 
following cardiac, blood vessel, or transplantation surgery have recently been described. 
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Rarely, Nocardia species organisms can be inoculated directly into the bloodstream during iv 
drug abuse or accidentally into a vein, producing local septic thrombophlebitis. 
7. Systemic involvement 
The most common sites for dissemination include the CNS (brain), skin and subcutaneous 
tissues, eyes (especially the retina), kidneys, joints, bones, and the heart. Unlike the primary 
pulmonary infection, lesions of disseminated or systemic nocardiosis progress unless 
treated. Self - limited or subclinical disease is not recognized frequently, although some CNS 
infections may evolve slowly over a period of many months or even years.  
CNS – Central nervous system involvement is a well-described complication of nocardial 
infection36. Most reviews of this problem have focused on nocardial brain abscess, whose 
typical clinical presentation is an intracranial space-occupying lesion. Recently, Nocardia has 
been cited as a cause of persistent neutrophilic pleocytosis resembling other subacute or 
chronic forms of meningitis in its clinical presentation and CSF findings. In a typical case of 
pyogenic brain abscess, headache is clearly the most common presenting compliant. The 
nature of the headache is characterized by dull aching that is poorly localized. Depression, 
schizophrenia, dyslexia and amnesia have also been recorded 37.  
 
Figure 6. Primary cutaneous nocardiosis with cranial and cerebral extension 
The most common source of microbial infection remains direct or indirect cranial infection 
(Figure 6) arising from the paranasal otogenic brain sinuses, middle ear, and teeth. Seeding 
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of the brain presumably occurs via transit of infecting bacteria through the valveless organ 
transplant. Although dental and sinus infections remain an important source of brain 
abscess. The typical presentation was subacute to chronic meningitis characterized by fever, 
stiff neck, and headache. CSF studies revealed neutrophilic pleocytosis, hypoglycorrhachia, 
and elevated protein level. CT and MRI scanning can help in diagnosis and management of 
brain abscess. CT scan with intravenous contrast of the brain with abscess will demonstrate 
ring-enhancing lesion. Needle aspiration or biopsy of a cerebral mass is not confirmatory for 
the diagnosis. 
Cerebral nocardiosis commonly accompanies pulmonary disease, but isolated CNS disease 
may occur. In immunocompetent patients, cerebral nocardiosis is less common and may 
resemble a brain tumor or vascular infarct 38,39. Central nervous system imaging should be 
considered for patients with any adverse neurologic symptoms, severe pulmonary 
nocardiosis, or significant immunosuppression. 
Other systemic involvement includes peritonitis, epididymo-orchitis, iliopsoas, ischiorectal 
and perirectal abscess, hematogenous endophthalmitis and retinitis, pericarditis, 
endocarditis, aortitis, septic arthritis and bursitis, peritonitis in chronic peritoneal dialysis, 
osteomyelitis, and a disseminated miliary picture with diffuse organ abscesses. 
Eye involvement like retinal infection or endophthalmitis, keratoconjunctivitis can  
occur. 
8. Nocardiosis and HIV 
Systemic Nocardia infections occur more frequently in immunocompromised patients. 
Nocardia species is recognized as an opportunistic pathogen for patients with impaired host 
defense mechanisms. 
Lymphoreticular malignancies, organ transplantation, corticosteroid or other 
immunosuppressive therapy, and underlying pulmonary disease are important 
predisposing factors 40,41,42. Uttamchandani et al. found a strong association of Nocardia 
infection with injection drug use 43. Nocardiosis occurred among patients with advanced 
HIV disease. The clinical features of nocardiosis in these HIV-infected patients were 
similar to those described in other immunocompromised patients. The duration of illness 
was typically chronic, and the signs and symptoms reflected the sites involved. The lung 
was the most commonly affected site. The chest radiographic features were variable and 
not specific for nocardiosis. The diagnosis of nocardiosis is often delayed because none 
of the clinical, laboratory or radiographic features are pathognomonic. The diagnosis 
therefore relies on the isolation of Nocardia species, which can be difficult, particularly 
when the specimens are contaminated with other microorganisms. Nocardiosis caused or 
contributed to the death of two thirds of the patients. The high fatality rate could be 
attributed to three factors: dissemination of the infection due to delayed institution of 
therapy, relapse of nocardiosis due to discontinuation of treatment, and severe immune 
dysfunction of the host. 
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9. Treatment 
Sulfonamides, including sulfadiazine and sulfisoxazole, have been the antimicrobials of 
choice to treat nocardiosis for the past 50 years despite bacteriostatic activity 44. Sulfadiazine 
can induce oliguria, azotemia, and crystalluria in patients who fail to maintain a high fluid 
intake. This complication can be prevented by alkalinizing the urine with oral sodium 
bicarbonate. Sulfisoxazole is equally effective and much less likely to cause oliguria.  
Trimethoprim-sulfamethoxazole (TMP-SMZ) is now most frequently used to treat this 
infection. Divided doses of 5 to 10 mg/kg per day of the trimethoprim component or 25 to 50 
mg/kg per day of sulfamethoxazole are recommended to produce sulfonamide serum 
concentrations between 100 and 150 g/mL. Adverse reactions to high-dose TMP-SMX 
therapy are frequent and include myelosuppression, hepatoxicity, and renal insufficiency. 
Trimethoprim-sulfamethoxazole is active against most Nocardia species; however, N 
otitidiscaviarum is commonly resistant to TMP-SMX 43. 90%-95% of pleuropulmonary 
infections respond favourably. However, in patients with disseminated disease, especially of 
the CNS, and/or patients with depressed CMI, certain factors may complicate the picture. 
Most important is the frequent occurrence of side effects in HIV-infected persons or organ 
transplant recipients: 44%-80% experience fever, skin rash, and/or neutropenia. HIV-
infected patients require long-term maintenance suppressive therapy and are particularly 
intolerant of the TMP-SMZ combination, manifesting severe hypersensitivity reactions, 
hepatotoxicity, and/or prolonged myelosuppression. In organ transplantation patients 
treated with the anti rejection medication cyclosporine, TMP-SMZ may cause reversible 
cyclosporine-induced nephrotoxicity. Daily TMP-SMX prophylaxis most reliably prevents 
nocardiosis compared to intermittent therapy with oral TMP-SMX (2 double-strength tablets 
twice weekly or 1 single strength tablet 3 times weekly) 45. Non immunosuppressed patients 
with pulmonary or systemic nocardiosis (excluding CNS involvement) should be treated for 
a minimum of 6-12 months and hose with CNS infection should be treated for 12 months. In 
one study of the efficacy of TMP-SMZ, relapse occurred rarely when patients received 
therapy for > 3 months 46. Parenteral therapy need not be continued beyond a period of 3-6 
weeks, as determined by response in individual patients. 
Alternatives to sulfonamides include amikacin, imipenem, meropenem, ceftriaxone, 
cefotaxime, minocycline, moxifloxacin, levofloxacin, linezolid, tigecycline, and amoxicillin - 
clavulanic acid 47,48. 
Linezolid is an oxazolidinone that has activity against most gram-positive bacteria, 
including in vitro activity against all Nocardia species and strains 49,50. Linezolid binds to 
a site on the bacterial 23S rRNA of the 50S subunit and prevents the formation of a 
functional 70S-initiation complex, which is an essential component of the bacterial 
translation process. Dose is 600 mg orally or iv twice daily. CNS nocardiosis is associated 
with significant morbidity and mortality. A number of recent reports have highlighted 
the excellent penetration of the CSF by linezolid after intravenous administration of the 
drug every 12 h.  
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Tigecycline, a glycylcycline, appears to be active in vitro against most Nocardia species. Of 
the fluoroquinolones, moxifloxacin is fairly active in vitro against asteroides complex. 
Combination therapy with imipenem and cefotaxime, amikacin and TMP-SMX, imipenem 
and TMP-SMX, amikacin and cefotaxime, or amikacin and imipenem may provide 
enhanced activity. Alternative oral drug therapy for nocardial infections theoretically might 
include dapsone because its mechanism of action (folate antagonism) is identical to that of 
the sulphonamides. 
Surgical intervention can be advised for the drainage or excision of abscesses or an 
empyema. 
 Primary Cutaneous Disseminated with skin 
Involvement 
Species N. brasiliensis N. asteroids 
Risk Factors Local trauma related to plants
And soil 
Immunosuppression 
Primay site Skin Lung 
Skin manifestations Acute: 
Lymphocutanoeus 
Superficial skin infections 
Chronic : 
Mycetoma 
Pustules 
Nodules 
Abscesses 
Diagnosis Direct Smear: Gram and acid fast stainin. Culture: Standard or 
Special media. 
Biochemical and molecular methods: DNA probing, PCR, PCR-
RFLP, 
Gene sequencing, ribotyping 
Treatment TMP-SMX; alternatives are amikacin, minocycline, imipenem, 
3rd generation cephalosporins, linezolid 
Duration of 
treatment 
Lymphocutaneous/ 
superficial: 
2-4 months 
Mycetoma: 12 months 
No CNS involvement or 
immunio- 
Suppression: 6-12 months 
CNS involvement or immunoi- 
Suppression: 12 months 
Prognosis Good but can recur Poor, mortality rate 44-85% 
Table 1. PCR: polymerase chain reaction. RFLP- fragment length polymorphism, TMP-SMZX 
trimethoprim- sulphomethoxazole 
10. Conclusion 
The spectrum of subcutaneous and deep mycoses is a very wide one. Of these, nocardiosis is 
becoming increasingly important especially in the era of HIV infections. Nocardiosis can 
present in diverse clinical manifestations, including cutaneous nodules, ulcerations, 
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subcutaneous abscesses, pyoderma like lesions, lymphangitis (sporotrichoid pattern), 
mycetoma like lesions. Moreover, the systemic spectrum of nocardiosis is also wide, 
including, pulmonary, central nervous system, eye, bone, and solid organs. Hence, unless a 
high index of suspicion is kept, nocardiosis can be either underdiagnosed or misdiagnosed. 
The usual diagnostic methods are histopathology and culture, though the gold standard 
remains PCR. Clinico pathological correlation is important for diagnosis. The treatment of 
nocardiosis essentially involves long term administration of chemotherapeutic agents like 
sulphonamides, cotrimoxazole, linezolid and amikacin. Early initiation of chemotherapy can 
avoid surgical excision which may be required in late or complicated cases. 
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